Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)

Med J Aust. 2017 May 15;206(9):412. doi: 10.5694/mja16.01357.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Antineoplastic Agents
  • Humans
  • Immunotherapy*
  • Neoplasms

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents